Fourier-OLE

Fourier-OLE

The purpose of the study is to assess long-term safety and tolerability of Evolocumab therapy in patients with clinically evident cardiovascular disease and to describe the effects on LDL-C. Patients must have completed the Fourier trial.

Please use this link for further information:

Primary Investigator: Dean Kereiakes